Skip to content

Aurobindo Pharma posts 12% slump in Q4 net profit at Rs 506 crore, revenue jumps 11%

The EBITDA came in at Rs 1,002 crore in Q4FY23, which is three percent higher as against Rs 974.4 crore recorded in the year-ago period.

Read More

​ The EBITDA came in at Rs 1,002 crore in Q4FY23, which is three percent higher as against Rs 974.4 crore recorded in the year-ago period. The EBITDA came in at Rs 1,002 crore in Q4FY23, which is three percent higher as against Rs 974.4 crore recorded in the year-ago period.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish